After more than a month of lobbying the provincial government to fund a life-sustaining treatment for their toddler, Aleena Sadownyk's family can breathe a sigh of relief. The family received word Monday that the province has approved the enzyme replacement therapy used to treat the extremely rare Maroteaux-Lamy Syndrome, also called MPS VI.
Read more >